Stereotactic Body Radiation Therapy for Unfavorable Intermediate- and High-Risk Prostate Cancer: 3-Year Outcomes of a Phase II Trial
2018 ◽
Vol 102
(3)
◽
pp. S105-S106
2020 ◽
Vol 108
(3)
◽
pp. e907-e908
2018 ◽
Vol 102
(3)
◽
pp. e121-e122
2020 ◽
Vol 108
(4)
◽
pp. 930-935
2016 ◽
Vol 95
(3)
◽
pp. 960-964
◽
2020 ◽
Vol 108
(3)
◽
pp. e899-e900
2015 ◽
Vol 91
(4)
◽
pp. 832-839
◽